PDS Biotech Reports An Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDS Biotechnology Corporation FLORHAM PARK, NJ Oct. 07, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:…

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharma SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 07, 2022 (GLOBE NEWSWIRE) — ORIC…

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Alektor, Inc. SOUTH SAN FRANCISCO, Calif. Oct. 06, 2022 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC),…

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cullinan Oncology, Inc. CAMBRIDGE, Mass., Oct. 3, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM)…

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer

Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO),…

PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PDS Biotechnology Corporation FLORHAM PARK, NJ, Sept. 23, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:…

Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Sept. 22, 2022–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused…

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SEATTLE, September 21, 2022 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ: CTIC) today announced the granting of…